{"title":"EEG-Based Deep Learning Model for Hyper-Acute Large Vessel Occlusion Stroke Detection in Mice","authors":"Tan Zhang, Xiaolin Li, Xinxin Hu, Zhiyong Zhou, Qingchun Mu, Xiaoke Chai, Qing Lan, Jizong Zhao","doi":"10.1111/cns.70592","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>This study aims to develop a deep learning model for the early and accurate detection of hyper-acute large vessel occlusion (LVO) stroke using EEG data.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A pMCAO mouse model was used to simulate LVO stroke, with high-resolution EEG data collected during the hyper-acute phase. <i>EEGNet</i>, a specialized deep learning architecture, was employed to develop a model based on EEG signals for the detection of hyper-acute LVO strokes. Seven-fold cross-validation was conducted to evaluate the model's performance across multiple metrics, including accuracy, AUC, precision, recall, and F1 score.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The model achieved an overall accuracy of 97.9% and an AUC of 0.977, demonstrating excellent diagnostic performance across the hyper-acute phase. Stroke detection was reliable within 1.5 h post-onset, with classification accuracies exceeding 95% in all five time intervals segmented by hour. t-SNE analysis confirmed effective feature extraction, and comparisons with sham-operated mice validated the model's specificity for stroke-related EEG changes.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The EEG-based deep learning model showed robust performance in hyper-acute LVO stroke detection, achieving high accuracy and specificity. These results highlight its potential as a biomarker for early stroke diagnosis and as a foundation for real-time, non-invasive monitoring in clinical and prehospital settings.</p>\n </section>\n </div>","PeriodicalId":154,"journal":{"name":"CNS Neuroscience & Therapeutics","volume":"31 9","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cns.70592","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Neuroscience & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cns.70592","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
This study aims to develop a deep learning model for the early and accurate detection of hyper-acute large vessel occlusion (LVO) stroke using EEG data.
Methods
A pMCAO mouse model was used to simulate LVO stroke, with high-resolution EEG data collected during the hyper-acute phase. EEGNet, a specialized deep learning architecture, was employed to develop a model based on EEG signals for the detection of hyper-acute LVO strokes. Seven-fold cross-validation was conducted to evaluate the model's performance across multiple metrics, including accuracy, AUC, precision, recall, and F1 score.
Results
The model achieved an overall accuracy of 97.9% and an AUC of 0.977, demonstrating excellent diagnostic performance across the hyper-acute phase. Stroke detection was reliable within 1.5 h post-onset, with classification accuracies exceeding 95% in all five time intervals segmented by hour. t-SNE analysis confirmed effective feature extraction, and comparisons with sham-operated mice validated the model's specificity for stroke-related EEG changes.
Conclusion
The EEG-based deep learning model showed robust performance in hyper-acute LVO stroke detection, achieving high accuracy and specificity. These results highlight its potential as a biomarker for early stroke diagnosis and as a foundation for real-time, non-invasive monitoring in clinical and prehospital settings.
期刊介绍:
CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.